Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Nicorandil, Diltiazem or Isosorbide Mononitrate for Oral Antispastic Therapy After Coronary Artery Bypass Grafting Using Radial Artery Grafts - A Pilot Randomized Controlled Trial

NCT04310995 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT04310995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04310995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Nicorandil, Diltiazem or Isosorbide Mononitrate for Oral Antispastic Therapy After Coronary Artery Bypass Grafting Using Radial Artery Grafts - A Pilot Randomized Controlled Trial
Lead sponsor
Ruijin Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 2, 2020
Completion date
May 31, 2026
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antispastic therapy, coronary artery bypass graft, pilot study, radial artery grafts